NGF regulates survival and differentiation of umbilical mesenchymal stem/stromal cells into GABAergic, dopaminergic and cholinergic lineages
Open Access
- 24 February 2025
- journal article
- Published by Elsevier in European Journal of Pharmaceutical Sciences
- Vol. 208, 107053
Abstract
No abstract availableKeywords
Funding Information
- Śląski Uniwersytet Medyczny w Katowicach (PCN-1-206/N/2/I)
- Medical University of Silesia in Katowice (KNW/0022/KB/195/14)
This publication has 48 references indexed in Scilit:
- Emerging roles of nerve‐bone axis in modulating skeletal systemMedicinal Research Reviews, 2024
- Nerve growth factor (NGF) and NGF receptors in mesenchymal stem/stromal cells: Impact on potential therapiesStem Cells Translational Medicine, 2021
- Introduction for Stem Cell–Based Therapy for Neurodegenerative Diseases2020
- Parkinson’s disease treatment: past, present, and futureJournal of Neural Transmission, 2020
- Evaluation of reference genes for quantitative real-time PCR in Wharton’s Jelly-derived mesenchymal stem cells after lentiviral transduction and differentiationMolecular Biology Reports, 2019
- Biological functions of mesenchymal stem cells and clinical implicationsCellular and Molecular Life Sciences, 2019
- Isolation, cultivation, and characterization of human mesenchymal stem cellsCytometry Part A, 2017
- Nerve Growth Factor Gene TherapyJAMA Neurology, 2015
- Role of mesenchymal stem cells in bone regeneration and fracture repair: a reviewInternational Orthopaedics, 2013
- The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cellsBreast Cancer Research and Treatment, 2011